Medgenics One2One Investor Presentation - 23rd June 2011
Medgenics One2One Investor Presentation - 23rd June 2011
View ArticleMedgenics CEO Andy Pearlman says there’s enormous opportunity with its...
Dr Andy Pearlman, CEO at Medgenics, tells Proactive Investors that the company’s patent, the Biopump, is an inexpensive, efficient and reliable method in treating chronic diseases. He says that with...
View ArticleMedgenics One2One Investor Presentation - 5th July 2012
Medgenics One2One Investor Presentation - 5th July 2012
View ArticleMedgenics CEO says a number of factors set the company at beneficial "tipping...
Dr Andy Pearlman, President CEO and Founder of Medgenics (AMEX:MDGN LON:MEDG), tells Proactiveinvestors that a number of things have come together: first validation of the clinical trial of EPODURE for...
View ArticleH₂0 Markets looks at AIM stocks
Michael Jarman, Chief Market Strategist at H₂0 Markets looks at the reasons why the AIM index has outperformed the FT100 year to date. Mike also says why he likes Medgenics (LON:MEDG), which he says is...
View Article
